Holden Lowell Thomas

CFO at Nascent Biotech Inc.

Sold, on record
$1k
Dollars the filings state
Form 4 sales
1
Latest Jul 21, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Nascent Biotech Inc.Plan not stated
    Jul 21, 2022 2022

    Sold 5,000 shares at $0.26 ($1k)

    Holden Lowell Thomas, CFO

    Sold 0.1% of holdings ($2.1M position)8.1M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Holden Lowell Thomas
Source
Jul 21, 2022Jul 25, 2022Nascent Biotech Inc.CFOForm 4 sale5,000$1k0.1%Plan not statedSEC